Omalizumab biosimilar (Hisun BioRay)
奥马佐单抗生物类似药 (海正药业)
Report date: 2026/03/20 20:03:07
Base Information
Drug NameOmalizumab biosimilar (Hisun BioRay)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A